Your browser doesn't support javascript.
loading
The dysfunctional immune response in renal cell carcinoma correlates with changes in the metabolic landscape of ccRCC during disease progression.
Annels, Nicola E; Denyer, M; Nicol, D; Hazell, S; Silvanto, A; Crockett, M; Hussain, M; Moller-Levet, Carla; Pandha, Hardev.
Afiliação
  • Annels NE; Oncology, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK.
  • Denyer M; Oncology, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK.
  • Nicol D; Royal Marsden Hospital, Fulham Road, London, UK.
  • Hazell S; Royal Marsden Hospital, Fulham Road, London, UK.
  • Silvanto A; Frimley Park Hospital, Frimley, Camberley, UK.
  • Crockett M; Frimley Park Hospital, Frimley, Camberley, UK.
  • Hussain M; Frimley Park Hospital, Frimley, Camberley, UK.
  • Moller-Levet C; Bioinformatics Core Facility, University of Surrey, Guildford, UK.
  • Pandha H; Oncology, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK. h.pandha@surrey.ac.uk.
Cancer Immunol Immunother ; 72(12): 4221-4234, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37940720

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article